GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL BTA) » Definitions » Notes Receivable

PharmaLundensis AB (XSAT:PHAL BTA) Notes Receivable : kr0.00 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is PharmaLundensis AB Notes Receivable?

PharmaLundensis AB's Notes Receivable for the quarter that ended in Mar. 2025 was kr0.00 Mil.


PharmaLundensis AB Notes Receivable Historical Data

The historical data trend for PharmaLundensis AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB Notes Receivable Chart

PharmaLundensis AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PharmaLundensis AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaLundensis AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


PharmaLundensis AB Notes Receivable Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaLundensis AB Business Description

Traded in Other Exchanges
Address
PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB Headlines

No Headlines